🇺🇸 FDA
Patent

US 11261152

Inhibitors of the N-terminal domain of the androgen receptor

granted A61KA61K31/121A61K31/137

Quick answer

US patent 11261152 (Inhibitors of the N-terminal domain of the androgen receptor) held by United States Government as represented by the Department of Veterans Affairs expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/121, A61K31/137, A61K31/336, A61P